Renown developed processes to standardize patient care, increase quality measurement
The American College of Cardiology has recognized Renown Health for its demonstrated expertise and commitment in treating patients receiving transcatheter valve repair and replacement procedures. Renown Health was awarded Transcatheter Valve Certification in February based on evaluation of the staff’s ability to meet standards for multidisciplinary teams, formalized training, shared decision-making and registry performance.
The ACC’s Transcatheter Valve Certification is an external review and certification process that pairs with established national clinical databases to monitor patient safety and real-world outcomes related to transcatheter valve therapies. Participation in established national clinical databases such as the STS/ACC TVT Registry is required for hospitals interested in achieving Transcatheter Valve Certification.
“Renown Health has demonstrated its commitment to providing northern Nevada with excellent heart care,” said Deepak L. Bhatt, MD, MPH, FACC, chair of the ACC Accreditation Management Board. “ACC Accreditation Services is proud to award Renown Health with Transcatheter Valve Certification.”
The certification uses established national clinical measures to support clinical decisions and links process improvement to patient outcomes. Hospitals that achieve Transcatheter Valve Certification learn best practices for implementing evidence-based medicine to support patient-centered decision-making and can track key performance metrics to better identify opportunities for improvement.
The nationally acclaimed Renown Institute for Heart & Vascular Health provides the region with top-tier cardiovascular care, including 11 cardiovascular specialties, 52 providers and 69,000 patient visits per year.
“Renown was the first healthcare system in the region to offer our patients the minimally invasive Transcatheter Aortic Valve Replacement (TAVR) and in 2022 our team performed 128 TAVR procedures, exceeding the national TAVR quality average,” said Dr. Jayson Morgan, FACC, Director of Cardiovascular Services. “This advanced 60-to-90-minute procedure treats aortic stenosis, a progressive disease that affects the aortic valve in the heart. During the procedure, a new valve is inserted within the diseased aortic valve while the heart is still beating.”
The ACC offers U.S. and international hospitals like Renown Health access to a comprehensive suite of cardiac accreditation services designed to optimize patient outcomes and improve hospital financial performance. These services are focused on all aspects of cardiac care, including transcatheter valve therapies.
Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health.
The American College of Cardiology (ACC) is the global leader in transforming cardiovascular care and improving heart health for all. As the preeminent source of professional medical education for the entire cardiovascular care team since 1949, ACC credentials cardiovascular professionals in over 140 countries who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. Through its world-renowned family of JACC Journals, NCDR registries, ACC Accreditation Services, global network of Member Sections, CardioSmart patient resources and more, the College is committed to ensuring a world where science, knowledge and innovation optimize patient care and outcomes. Learn more at acc.org or follow @ACCinTouch.
